Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

2,670 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Efficacy and safety of fezolinetant for moderate to severe vasomotor symptoms associated with menopause among women in East Asia: a phase 3 randomized study (MOONLIGHT I).
Ruan X, Bai W, Ren M, Kim T, Lee JY, Chuang FC, Wang PH, He W, Ma X, Miyazaki K, Song N, Wang X, Yu Q. Ruan X, et al. Among authors: miyazaki k. J Int Med Res. 2024 May;52(5):3000605241247684. doi: 10.1177/03000605241247684. J Int Med Res. 2024. PMID: 38818888 Free PMC article. Clinical Trial.
Efficacy and safety of fezolinetant for moderate-severe vasomotor symptoms associated with menopause in individuals unsuitable for hormone therapy: phase 3b randomised controlled trial.
Schaudig K, Wang X, Bouchard C, Hirschberg AL, Cano A, Shapiro C M M, Stute P, Wu X, Miyazaki K, Scrine L, Nappi RE. Schaudig K, et al. Among authors: miyazaki k. BMJ. 2024 Nov 18;387:e079525. doi: 10.1136/bmj-2024-079525. BMJ. 2024. PMID: 39557487 Free PMC article. Clinical Trial.
Efficacy and safety of ASP1707 for endometriosis-associated pelvic pain: the phase II randomized controlled TERRA study.
D'Hooghe T, Fukaya T, Osuga Y, Besuyen R, López B, Holtkamp GM, Miyazaki K, Skillern L. D'Hooghe T, et al. Among authors: miyazaki k. Hum Reprod. 2019 May 1;34(5):813-823. doi: 10.1093/humrep/dez028. Hum Reprod. 2019. PMID: 31067329 Free PMC article. Clinical Trial.
Skillern are employed by Astellas Pharma Europe B.V.; K. Miyazaki is employed by Astellas Pharma Inc.; B. Lopez, was a biostatistician for Astellas Pharma Europe B.V. during conduct of the study; R. ...
Skillern are employed by Astellas Pharma Europe B.V.; K. Miyazaki is employed by Astellas Pharma Inc.; B. Lopez, was a biostat …
Prognostic value of systemic immune-inflammation index in patients with small-cell lung cancer treated with immune checkpoint inhibitors.
Hamakawa Y, Hirahara A, Hayashi A, Ito K, Shinohara H, Shiba A, Higashi Y, Aga M, Miyazaki K, Taniguchi Y, Misumi Y, Agemi Y, Nakamura Y, Shimokawa T, Okamoto H. Hamakawa Y, et al. Among authors: miyazaki k. BMC Cancer. 2025 Jan 6;25(1):17. doi: 10.1186/s12885-025-13440-5. BMC Cancer. 2025. PMID: 39762819 Free PMC article.
Outcomes of Combined Atezolizumab Plus Chemotherapy in Non-small Cell Lung Cancer Patients in Clinical Practice.
Numata T, Nakamura R, Shiozawa T, Watanabe H, Okauchi S, Ogara G, Tamura T, Kikuchi N, Miyazaki K, Hayashi S, Yamashita T, Kurishima K, Inagaki M, Satoh H, Kaburagi T, Endo T, Hizawa N. Numata T, et al. Among authors: miyazaki k. Cancer Diagn Progn. 2025 Jan 3;5(1):105-114. doi: 10.21873/cdp.10418. eCollection 2025 Jan-Feb. Cancer Diagn Progn. 2025. PMID: 39758245 Free PMC article.
2,670 results